Success Metrics

Clinical Success Rate
93.3%

Based on 14 completed trials

Completion Rate
93%(14/15)
Active Trials
0(0%)
Results Posted
29%(4 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
6
32%
Ph phase_2
6
32%
Ph phase_4
7
37%

Phase Distribution

0

Early Stage

6

Mid Stage

7

Late Stage

Phase Distribution19 total trials
Phase 2Efficacy & side effects
6(31.6%)
Phase 4Post-market surveillance
7(36.8%)
N/ANon-phased studies
6(31.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.3%

14 of 15 finished

Non-Completion Rate

6.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Completed(14)
Terminated(1)
Other(4)

Detailed Status

Completed14
unknown4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Phase 26 (31.6%)
Phase 47 (36.8%)
N/A6 (31.6%)

Trials by Status

terminated15%
unknown421%
completed1474%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT05951400Phase 2

Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI

Completed
NCT03680053Not Applicable

Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF

Terminated
NCT02478775Not Applicable

Dysregulation of FSH in Obesity: Functional and Statistical Analysis

Completed
NCT04727671Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

Completed
NCT04727684Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

Completed
NCT04724486Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

Completed
NCT04724343Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

Completed
NCT05738382Phase 2

Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

Unknown
NCT04094467Phase 4

Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection

Unknown
NCT03118830Phase 4

Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

Completed
NCT02823080Phase 2

Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome

Unknown
NCT01457703Not Applicable

Reproductive Hormonal Alterations in Obesity

Completed
NCT02784457Phase 2

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

Completed
NCT01225835Phase 4

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)

Completed
NCT00667758Phase 2

Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis

Completed
NCT01468441Not Applicable

Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days

Completed
NCT01595334Not Applicable

Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity

Unknown
NCT00244452Phase 2

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

Completed
NCT00628121Not Applicable

Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19